-
CGT Global Appoints Dr. Andrew Branagan to Board of Advisors, Expanding Cell and Gene Therapy Expertise
07 Aug 2025 13:06 GMT
Dr. Branagan is board-certified in Internal Medicine, Medical Oncology, and Hematology. He focuses on developing novel immune-based cancer therapies, medical education, and global health. He is also an active member of several professional organizations, …
-
Cell and Gene Therapy Third-Party Logistics Market Trends Report 2025-2033 | Surging Demand Drives Growth in Patient-Centric, Specialized Logistics and 3PL Partnerships - ResearchAndMarkets.com
07 Aug 2025 12:59 GMT
DUBLIN--(BUSINESS WIRE)--Aug 7, 2025--
×
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
kAm%96 v=@32= r6== 2?5 v6?6 %96C2AJ %9:C5\!2CEJ {@8:DE:4D |2C<6E :D 6IA64E65 E@ C6249 &$S a_]hg 3 …
-
Around the Helix: Cell and Gene Therapy Company Updates – August 6, 2025
07 Aug 2025 09:54 GMT
The cell and gene therapy sectors are growing exponentially …
Have a cell and gene therapy news update you’d … virus (AAV) vector-based gene therapy delandistrogene moxeparvovec-rokl (marketed … commercial rights for the gene therapy product in markets outside …
-
China Focus: China's gene therapy research making strides to restore sight for RP patients
07 Aug 2025 06:55 GMT
… vision, thanks to a groundbreaking gene therapy injection that, within months, restored … 's research into the gene therapy drug GA001. "This significantly … , the world's first gene therapy for inherited retinal disease, marking …
-
Vial Adapter Considerations for Cell and Gene Therapy Applications
07 Aug 2025 05:45 GMT
-
Is the tide turning on viral vectors? The shifting landscape of gene therapy delivery
07 Aug 2025 04:42 GMT
… was the first ever gene therapy approved by the FDA for … the lowest titer of the gene therapy; all patients were pediatric, … associated with AAVrh74, a gene therapy for DMD and limb-girdle … in the world to receive gene therapy for a neuromuscular disorder …
-
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman
06 Aug 2025 21:44 GMT
… of its critical RP-A501 gene therapy trial for Danon disease. The … strong progress in advancing our gene therapy” and cited the Phase 1 …
-
Sarepta’s Future in Gene Therapy Remains Clouded, But Data From Partner Hansa Is a Bright Spot
06 Aug 2025 20:40 GMT
… its commercialized Duchenne muscular dystrophy gene therapy. But Sarepta partner Hansa … Duchenne patients dosed with the gene therapy, Elevidys.
In three Duchenne … approved gene therapy for Duchenne. The first fatality associated with this gene therapy …
-
Children’s Hospital Administers First Commercially Available Gene Therapy for Hemophilia B
06 Aug 2025 16:58 GMT
… s first commercially available gene therapy for hemophilia B to … FDA-approved, commercially available gene therapy for hemophilia B.
“It … helped start the hemophilia gene therapy program at hospital. “ … best for him.”
The gene therapy the man received, HEMGENIX …
-
Beyond Gene Therapy: Pyruvate Kinase Activators (Agios, Novo Nordisk) Offer a New Route to Address Hemoglobin, VOCs, and Transfusion Burden in Sickle Cell Disease
06 Aug 2025 14:16 GMT
… to curative options such as gene therapy. As the treatment paradigm evolves …